These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
2020 related items for PubMed ID: 15631176
21. Extended spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae isolated in a rural hospital. Basak S, Mallick SK, Bose S. J Indian Med Assoc; 2009 Dec; 107(12):855-8. PubMed ID: 20509468 [Abstract] [Full Text] [Related]
28. Extended spectrum beta-lactamase producing organisms at the University Hospital of the West Indies. Nicholson AM, Gayle P, Roye-Green K. West Indian Med J; 2004 Mar; 53(2):104-8. PubMed ID: 15199721 [Abstract] [Full Text] [Related]
29. Antibacterial susceptibility of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli. Bishara J, Livne G, Ashkenazi S, Levy I, Pitlik S, Ofir O, Lev B, Samra Z. Isr Med Assoc J; 2005 May; 7(5):298-301. PubMed ID: 15909461 [Abstract] [Full Text] [Related]
30. Dissemination of SHV-12 and CTX-M-type extended-spectrum beta-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae and emergence of GES-3 in Korea. Ryoo NH, Kim EC, Hong SG, Park YJ, Lee K, Bae IK, Song EH, Jeong SH. J Antimicrob Chemother; 2005 Oct; 56(4):698-702. PubMed ID: 16141280 [Abstract] [Full Text] [Related]
31. Molecular epidemiology of extended-spectrum β-lactamase-, AmpC β-lactamase- and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian hospitals over a 5 year period: CANWARD 2007-11. Denisuik AJ, Lagacé-Wiens PR, Pitout JD, Mulvey MR, Simner PJ, Tailor F, Karlowsky JA, Hoban DJ, Adam HJ, Zhanel GG, Canadian Antimicrobial Resistance Alliance. J Antimicrob Chemother; 2013 May; 68 Suppl 1():i57-65. PubMed ID: 23587779 [Abstract] [Full Text] [Related]
32. [Antibiotic resistance rates of extended spectrum beta-lactamase producing Escherichia coli and Klebsiella spp. strains isolated from urinary tract infections in a private hospital]. Akyar I. Mikrobiyol Bul; 2008 Oct; 42(4):713-5. PubMed ID: 19149097 [Abstract] [Full Text] [Related]
36. Prevalence, antibiotic susceptibility pattern and production of extended-spectrum beta-lactamases amongst clinical isolates of Klebsiella pneumoniae at Armed Forces Hospital in Saudi Arabia. Ahmad S, Al-Juaid NF, Alenzi FQ, Mattar EH, Bakheet Oel-S. J Coll Physicians Surg Pak; 2009 Apr; 19(4):264-5. PubMed ID: 19356348 [Abstract] [Full Text] [Related]
37. Occurrence of extended-spectrum beta-lactamase in clinical isolates of Klebsiella pneumoniae in a University Hospital, Thailand. Kusum M, Wongwanich S, Dhiraputra C, Pongpech P, Naenna P. J Med Assoc Thai; 2004 Sep; 87(9):1029-33. PubMed ID: 15516002 [Abstract] [Full Text] [Related]
38. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics]. Susić E. Acta Med Croatica; 2004 Sep; 58(4):307-12. PubMed ID: 15700687 [Abstract] [Full Text] [Related]
39. High incidence of extended-spectrum beta-lactamases among outpatient clinical isolates of Escherichia coli: a phenotypic assessment of NCCLS guidelines and a commercial method. Sorlózano A, Gutiérrez J, Palanca M, Soto MJ, Piédrola G. Diagn Microbiol Infect Dis; 2004 Oct; 50(2):131-4. PubMed ID: 15474323 [Abstract] [Full Text] [Related]